| 1 | Higher Intra-Abdominal Visceral Adipose Tissue Mass Is Associated With Lower Rates of Clinical and Endoscopic Remission in Patients With Inflammatory Bowel Diseases Initiating Biologic Therapy: Results of the Constellation Study. (Yarur AJ, Bruss A, Moosreiner A, Beniwal-Patel P, Nunez L, Berens B, Colombel JF, Targan SR, Fox C, Melmed GY, Abreu MT, Deepak P) Gastroenterology 2023 Oct;165(4):963-975.e5 50 Citations |
| 1 | Lactobacillus crispatus Limits Bladder Uropathogenic E. coli Infection by Triggering a Host Type I Interferon Response. (Song CH, Kim YH, Naskar M, Hayes BW, Abraham MA, Noh JH, Suk G, Kim MJ, Cho KS, Shin M, Lee EJ, Abraham SN, Choi HW) Proc Natl Acad Sci U S A 2022 Aug 16;119(33):e2117904119 37 Citations |
| 1 | Is Biologic Therapy in Inflammatory Bowel Disease Contributing to the Obesity Epidemic? Just Weight One Year. (Mulgund A, Stein D) Dig Dis Sci 2020 Dec;65(12):3420-3421 1 Citation |
| 1 | Efficacy of risankizumab in patients with moderate-to-severe plaque psoriasis by baseline demographics, disease characteristics and prior biologic therapy: an integrated analysis of the phase III UltIMMa-1 and UltIMMa-2 studies. (Strober B, Menter A, Leonardi C, Gordon K, Lambert J, Puig L, Photowala H, Longcore M, Zhan T, Foley P) J Eur Acad Dermatol Venereol 2020 Dec;34(12):2830-2838 56 Citations |
| 1 | Biologic therapy in psoriasis: navigating the options. (McKay C, Kondratuk KE, Miller JP, Stumpf B, Boh E) Cutis 2018 Nov;102(5S):13-17 5 Citations |
| 2 | Protein engineering of the chemokine CCL20 prevents psoriasiform dermatitis in an IL-23-dependent murine model. (Getschman AE, Imai Y, Larsen O, Peterson FC, Wu X, Rosenkilde MM, Hwang ST, Volkman BF) Proc Natl Acad Sci U S A 2017 Nov 21;114(47):12460-12465 50 Citations |
| 1 | Intratumoral Clostridium novyi as a potential treatment for solid necrotic brain tumors. (Zwagerman NT, Friedlander RM, Monaco EA 3rd) Neurosurgery 2014 Dec;75(6):N17-8 8 Citations |
| 1 | Update on the treatment of juvenile idiopathic arthritis. (Harris JG, Kessler EA, Verbsky JW) Curr Allergy Asthma Rep 2013 Aug;13(4):337-46 36 Citations |
| 1 | Long-term efficacy of biologics in the treatment of psoriasis: what do we really know? (Alwawi EA, Krulig E, Gordon KB) Dermatol Ther 2009;22(5):431-40 39 Citations |
| 1 | From laboratory to clinic: rationale for biologic therapy. (Mehlis S, Gordon KB) Dermatol Clin 2004 Oct;22(4):371-7, vii-viii 15 Citations |
| 1 | Evolution of biologic therapies for the treatment of psoriasis. (Gordon KB, McCormick TS) Skinmed 2003;2(5):286-94 11 Citations |